novavax featured image
News Pharmaceutical & Biotech Stories

Novavax to Supply 40M Doses of COVID Vaccine Candidate to Australia

Wednesday, November 4, Novavax has reached an arrangement to provide the Australian government with 40 million of its COVID-19 vaccine candidate.

Novavax, among the handful of companies that are conducting late-stage trials of experimental COVID-19 vaccines, has already signed separate deals to supply its shot to the United States, the UK, Canada, Japan, South Korea, and India.

The drugmaker said it will deliver its vaccine to Australia starting as early as the first half of 2021.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS

Send this to a friend